IDiyas

For the Inventor, By the Inventor

Langenzenn, Germany

Peter Morsdorf

USPTO Granted Patents = 18

 

Average Co-Inventor Count = 5.6

ph-index = 4

Forward Citations = 86(Granted Patents)


Location History:

  • Cadolzburg, DE (1985 - 1988)
  • Langenzehn, DE (1990)
  • Langenzenn, DE (1988 - 1993)

Company Filing History:

goldMedal10 out of 17 
 
Heumann Pharma Gmbh & Co.
 patents
silverMedal8 out of 23 
 
Ludwig Heumann & Co. Gmbh
 patents

Years Active: 1985-1993

Loading Chart...
Loading Chart...
18 patents (USPTO):Explore Patents
1. 5182294 - Imidazolyl propyl guanidine derivative and a pharmaceutical composition (1993-01-26),
2. 5108998 - Cardiotonic thiadiazine derivatives (1992-04-28),
3. 5039675 - Benzimidazoles and pharmaceutical preparations containing these compounds (1991-08-13),
4. 4968683 - 6-oxo-pyridazine derivatives, a process for their preparation and (1990-11-06),
5. 4957920 - Benzimidazoles, and pharmaceutical preparations containing these (1990-09-18),
6. 4954501 - Piperazine substituted 6-phenyldihydro-3(2H)-pyridazinones, and (1990-09-04),
7. 4948802 - Guanidine carboxylic acid esters and pharmaceutical preparations (1990-08-14),
8. 4921856 - Dihydropyridazinone derivatives, a process for their preparation and (1990-05-01),
9. 4912119 - Imidazolylguanidine derivatives and compositions containing these (1990-03-27),
10. 4757080 - 1,4-dihydropyridine derivatives (1988-07-12),
11. 4732986 - Benzothiazole derivatives, processes for their preparation and (1988-03-22),
12. 4666921 - Pyrazole derivatives, processes for their preparation and pharmaceutical (1987-05-19),
13. 4659721 - Alkanol derivatives, and pharmaceutical preparation containing these (1987-04-21),
14. 4656180 - Diamine derivatives and pharmaceutical preparations containing these (1987-04-07),
15. 4600721 - Pharmaceutical preparation (1986-07-15),

Title: The Innovative Contributions of Peter Morsdorf

Introduction: Peter Morsdorf is a distinguished inventor based in Langenzenn, Germany, renowned for his innovative contributions to the pharmaceutical field. With a remarkable portfolio of 18 patents, Morsdorf has significantly impacted the treatment of cardiovascular diseases through his groundbreaking inventions.

Latest Patents: Among his latest inventions are two notable patents focusing on novel compounds for cardiovascular treatment. The first patent describes an imidazolyl propyl guanidine derivative that offers a combination of beneficial properties for treating heart and circulation diseases. The second patent introduces cardiotonic thiadiazine derivatives, which are new positive inotropic compounds demonstrating enhanced and selective action compared to previously known compounds. These innovations are aimed at improving the treatment and prevention of heart-related ailments.

Career Highlights: Throughout his career, Morsdorf has collaborated with reputable companies, including Heumann Pharma GmbH & Co. and Ludwig Heumann & Co. GmbH. His work in these organizations has further advanced pharmaceutical research and development focused on cardiovascular health.

Collaborations: Morsdorf has worked closely with notable colleagues, including Helmut Schickaneder and Kurt H. Ahrens. These collaborations have contributed to the successful development of his patents and the advancement of medical science in treating heart diseases.

Conclusion: Peter Morsdorf stands as an influential figure in the realm of innovation, particularly in pharmaceutical advancements. His dedication to developing new therapeutic compounds reflects his commitment to improving cardiovascular treatments, ultimately benefiting countless patients around the world. His extensive patent portfolio exemplifies the vital role of inventors in addressing healthcare challenges and advancing medical knowledge.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…